Wealth Alliance Advisory Group’s iShares Biotechnology ETF IBB Stock Holding History

Wealth Alliance Advisory Group’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-1,360	Closed	-$208K	–	163
2021 Q4	$208K	Hold	1,360	–	–	0.09%	151
2021 Q3	$220K	Hold	1,360	–	–	0.11%	131
2021 Q2	$223K	Hold	1,360	–	–	0.11%	134
2021 Q1	$205K	Sell	1,360 -70	-5%	-$11.1K	0.11%	142
2020 Q4	$217K	Sell	1,430 -64	-4%	-$9.15K	0.12%	133
2020 Q3	$202K	Buy	+1,494	New	+$203K	0.12%	119
2019 Q2	–	Sell	-2,794	Closed	-$295K	–	129
2019 Q1	$295K	Buy	+2,794	New	+$306K	0.19%	87

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Wealth Alliance Advisory Group's IBB Position: Q1 2022 in Review

Wealth Alliance Advisory Group sold out of iShares Biotechnology ETF (IBB) in Q1 2022, closing a stake of 1,360 shares — an estimated $208K sold.

Wealth Alliance Advisory Group first reported a position in IBB in Q1 2019 and held it in 7 quarters. The position peaked at $295K in Q1 2019. 897 funds tracked by Wall St. Rank hold IBB as of Q1 2022.

Wealth Alliance Advisory Group reported no remaining iShares Biotechnology ETF position as of Q1 2022 after selling out during the quarter.
Wealth Alliance Advisory Group sold 1,360 iShares Biotechnology ETF shares in Q1 2022, an estimated $208K.
Wealth Alliance Advisory Group first reported a position in iShares Biotechnology ETF in Q1 2019 and held it in 7 quarters.
Wealth Alliance Advisory Group's iShares Biotechnology ETF position peaked at $295K in Q1 2019.
897 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2022.

Based on Wealth Alliance Advisory Group's 13F filing for Q1 2022, filed 18 Apr 2022.